Cargando…
The Effect of Sunitinib Treatment in Human Melanoma Xenografts: Associations with Angiogenic Profiles()
The effect of antiangiogenic agents targeting the vascular endothelial growth factor A (VEGF-A) pathway has been reported to vary substantially in preclinical studies. The purpose of this study was to investigate the effect of sunitinib treatment on tumor vasculature and oxygenation in melanoma xeno...
Autores principales: | Gaustad, Jon-Vidar, Simonsen, Trude G., Andersen, Lise Mari K., Rofstad, Einar K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293738/ https://www.ncbi.nlm.nih.gov/pubmed/28167241 http://dx.doi.org/10.1016/j.tranon.2016.12.007 |
Ejemplares similares
-
Antiangiogenic agents targeting different angiogenic pathways have opposite effects on tumor hypoxia in R-18 human melanoma xenografts
por: Gaustad, Jon-Vidar, et al.
Publicado: (2017) -
Sunitinib treatment does not improve blood supply but induces hypoxia in human melanoma xenografts
por: Gaustad, Jon-Vidar, et al.
Publicado: (2012) -
Magnetic resonance imaging identifies early effects of sunitinib treatment in human melanoma xenografts
por: Gaustad, Jon-Vidar, et al.
Publicado: (2013) -
Vascular abnormalities and development of hypoxia in microscopic melanoma xenografts
por: Gaustad, Jon-Vidar, et al.
Publicado: (2017) -
Vascularization, Oxygenation, and the Effect of Sunitinib Treatment in Pancreatic Ductal Adenocarcinoma Xenografts
por: Gaustad, Jon-Vidar, et al.
Publicado: (2019)